Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles

Show document
A+ | A- | | SLO | ENG

Title:	Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles
Authors:	ID De Marco, Ario, University of Nova Gorica (Author) ID Barile, Lucio, Cardiocentro Ticino Institute (Author)
Files:	This document has no files that are freely available to the public. This document may have a physical copy in the library of the organization, check the status via COBISS.
Language:	English
Work type:	Not categorized
Typology:	1.03 - Other scientific articles
Organization:	UNG - University of Nova Gorica
Keywords:	Extracellular vesicles, SARS-CoV-2, targeted delivery
Year of publishing:	2022
Number of pages:	41-42
Numbering:	25
PID:	20.500.12556/RUNG-7260
COBISS.SI-ID:	104572419
NUK URN:	URN:SI:UNG:REP:KYHDXGQG
Publication date in RUNG:	12.04.2022
Views:	3057
Downloads:	0
Metadata:
:	DE MARCO, Ario and BARILE, Lucio, 2022, Good reasons for targeting SARS-CoV-2 by engineered extracellular vesicles. Molecular Therapy - Methods and Clinical Development [online]. 2022. Vol. 25, p. 41–42. [Accessed 7 April 2025]. Retrieved from: https://repozitorij.ung.si/IzpisGradiva.php?lang=eng&id=7260 Copy citation

Average score:	0.5 1 1.5 2 2.5 3 3.5 4 4.5 5 (0 votes)
Your score:	Voting is allowed only for logged in users.
Share:

Similar works from our repository:

Similar works from other repositories:

No similar works found

Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Title:	Molecular Therapy - Methods and Clinical Development
Year of publishing:	2022

License:	CC BY-NC-ND 4.0, Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International

Link:	http://creativecommons.org/licenses/by-nc-nd/4.0/
Description:	The most restrictive Creative Commons license. This only allows people to download and share the work for no commercial gain and for no other purposes.
Licensing start date:	12.04.2022

Back